US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

SciSparc Ltd.

0.3200

+0.00973.13%

Volume:96.49K

Turnover:29.88K

Market Cap:3.59M

PE:-0.30

High:0.3200

Open:0.3004

Low:0.3004

Close:0.3103

Loading ...

Overview Company News Filings

SciSparc announces publication of Japanese patent application

SciSparc Ltd. Announces Japanese Patent for Novel Pain Relief Combination Therapy

SciSparc Ltd. Unveils New Compensation Policy for Executive Officers and Directors, Emphasizing Equity-Based Awards and Market-Comparable Benefits

Psychedelic: Clearmind completes clinical site initiations for AUD trial

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

Psychedelic: Exclusive talk with biotech company Clearmind Medicine

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

BRIEF-Scisparc, Clearmind apply for patent in South Korea for its co-developed treatment to overcome cocaine addiction

Scisparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea

THOMSON REUTERS

SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea

Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea

BRIEF-SciSparc Signs Definitive Agreement To Sell Mitocarex

SciSparc signs definitive agreement to sell MitoCareX to N2OFF

Scisparc Signs Definitive Agreement to Sell Mitocarex, Computational Drug Discovery Company Targeting Resistant Cancers

THOMSON REUTERS

SciSparc Signs Definitive Agreement to Sell MitoCareX, Computational Drug Discovery Company Targeting Resistant Cancers

Scisparc Ltd: on Feb 25, Co Entered Securities Purchase Agreements to Sell, Issue to Debentures in Aggregate Principal Amount of $4.2 Mln

THOMSON REUTERS

SciSparc extends $2M loan to support AutoMax growth

Scisparc Extends $2 Million Loan to Support Automax's Growth Following Automax’s Entry Into Direct Import of Jac Electric Vehicles

THOMSON REUTERS

SciSparc Extends $2 Million Loan to Support AutoMax's Growth Following AutoMax’s Entry into Direct Import of JAC Electric Vehicles

N2OFF to Acquire Biotech Firm MitoCareX Bio; Shares Fall

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SPRC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPRC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRC\",,,,,undefined,":{"symbol":"SPRC","market":"US","secType":"STK","nameCN":"SciSparc Ltd.","latestPrice":0.32,"timestamp":1749487563334,"preClose":0.3103,"halted":0,"volume":96493,"delay":0,"floatShares":11202886,"shares":11225751,"eps":-1.078803,"marketStatus":"Trading","change":0.0097,"latestTime":"06-09 12:46:29 EDT","open":0.3004,"high":0.32,"low":0.3004,"amount":29875.82010985,"amplitude":0.063165,"askPrice":0.32,"askSize":400,"bidPrice":0.3101,"bidSize":176,"shortable":3,"etf":0,"ttmEps":-1.078803,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1749499200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.3103,"preHourTrading":{"tag":"盘前","latestPrice":0.3111,"preClose":0.3103,"latestTime":"09:29 EDT","volume":184,"amount":57.362097520000006,"timestamp":1749475766226},"postHourTrading":{"tag":"盘后","latestPrice":0.31,"preClose":0.312,"latestTime":"19:55 EDT","volume":1214,"amount":373.8263,"timestamp":1749254130248},"volumeRatio":1.741324},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRC\",,,,,undefined,":{"symbol":"SPRC","floatShares":11202886,"roa":"-42.05%","roe":"-80.66%","lyrEps":-1.078803,"volumeRatio":1.741324,"shares":11225751,"dividePrice":0,"high":0.32,"amplitude":0.063165,"preClose":0.3103,"low":0.3004,"week52Low":0.197,"pbRate":"0.44","psRate":"2.75","week52High":1.79,"institutionHeld":0,"latestPrice":0.32,"committee":-0.388889,"eps":-1.078803,"divideRate":0,"volume":96493,"delay":0,"ttmEps":-1.078803,"open":0.3004,"prevYearClose":0.36,"prevWeekClose":0.312,"prevMonthClose":0.3138,"prevQuarterClose":0.2902,"fiveDayClose":0.316,"twentyDayClose":0.3443,"sixtyDayClose":0.345},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPRC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2538246304","title":"SciSparc announces publication of Japanese patent application","url":"https://stock-news.laohu8.com/highlight/detail?id=2538246304","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538246304?lang=en_us&edition=fundamental","pubTime":"2025-05-27 19:35","pubTimestamp":1748345705,"startTime":"0","endTime":"0","summary":"SciSparc (SPRC)announced the publication of a Japanese divisional patent. The patent application introduces a novel pharmaceutical combination of p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scisparc-announces-publication-of-japanese-patent-application-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scisparc-announces-publication-of-japanese-patent-application-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SPRC","BK4139"],"gpt_icon":0},{"id":"2538637814","title":"SciSparc Ltd. Announces Japanese Patent for Novel Pain Relief Combination Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2538637814","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538637814?lang=en_us&edition=fundamental","pubTime":"2025-05-27 19:32","pubTimestamp":1748345532,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scisparc Ltd. published the original content used to generate this news brief via GlobeNewswire  on May 27, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nNDL5q2Wt4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4588","LU2210150020.SGD","IE00B64PRP62.GBP","SPRC","BK4139","BK4112","LU2095319765.USD","BK4585","LU2210149790.SGD","BK4007","NDAQ","IE00B3QW5Z07.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2537995624","title":"SciSparc Ltd. Unveils New Compensation Policy for Executive Officers and Directors, Emphasizing Equity-Based Awards and Market-Comparable Benefits","url":"https://stock-news.laohu8.com/highlight/detail?id=2537995624","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537995624?lang=en_us&edition=fundamental","pubTime":"2025-05-22 04:02","pubTimestamp":1747857754,"startTime":"0","endTime":"0","summary":"SciSparc Ltd. Unveils New Compensation Policy for Executive Officers and Directors, Emphasizing Equity-Based Awards and Market-Comparable Benefits. SciSparc Ltd. has announced a new Compensation Policy for its Executive Officers and Directors, effective as of 2025. The policy outlines a structured approach to executive compensation, including base salaries tailored to individual qualifications and roles, as well as potential cash bonuses. Additional benefits, such as company cars, travel reimbursements, and professional development opportunities, are also part of the package. Furthermore, the policy includes equity-based compensation options, such as share options and restricted stock units, in alignment with the company's equity incentive plan. This policy aims to maintain a balanced compensation structure within the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely inform","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL2lDQQY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRC","BK4007","BK4139"],"gpt_icon":0},{"id":"2530215933","title":"Psychedelic: Clearmind completes clinical site initiations for AUD trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2530215933","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530215933?lang=en_us&edition=fundamental","pubTime":"2025-04-25 23:30","pubTimestamp":1745595026,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on site initiations, dosing completion and clinical site partnerships.Discover outperforming stocks and invest smarter with Top Smart Score Stocks.Filter, analyze, and streamline your search for investment opportunities using  Tipranks' Stock Screener.“AUD remains one of the most urgent and underserved public health challenges globally,” said Dr. Adi Zuloff-Shani, CEO. “With millions affected and current treatments often falling short, the study initiation for our FDA-approved CMND-100 trial marks a critical step toward potentially transforming the treatment landscape for alcoholism. We are honored to collaborate with world renowned institutions such as Yale and Johns Hopkins as we advance our mission to potentially provide safe, effective, and innovative solutions for individuals those suffering from alcoholism.”“Completing dosing of all participants in Part A of our 005 tria","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-clearmind-completes-clinical-initiations-153026935.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-clearmind-completes-clinical-initiations-153026935.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IXHL","MIRA","DRUG","BK4202","MYCOF","ENVB","BK4539","PBM","SPRC","CYBN","GHRS","MNMD","NUMIF","BK4547","ALID","OPTHF","SILO","CMPS","RLMD","BETRF","MDXXF","ENTBF","FLHLF","NRXP","AGNPF","BK4168","BK4007","SEEL","ATAI","SNPX","BK4139","PHRRF","RVVTF","PSYGF","QNTM","KTTA","CMND"],"gpt_icon":0},{"id":"2530184089","title":"SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2530184089","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530184089?lang=en_us&edition=fundamental","pubTime":"2025-04-25 19:59","pubTimestamp":1745582340,"startTime":"0","endTime":"0","summary":"TEL AVIV, Israel, April 25, 2025  -- SciSparc Ltd.  , a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced today that its collaboration with Clearmind Medicine Inc.  has led to the filing of a new international patent application for a proprietary treatment targeting anorexia, bulimia and other eating disorders.Eating disorders are serious mental health conditions that negatively impact an individual’s health, emotions, and ability to perform daily functions. Eating disorders are among the top ten leading causes of disability among young women and have one of the highest mortality rates compared to other mental disorders. According to recent studies, up to 70 million people globally are affected by eating disorders, with significant increases observed among children and adolescents. Global eating disorder prevalence increased from 3.4% to 7.8% between 2000 and 2018.Common shares of Clearmi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scisparc-clearmind-collaboration-leads-filing-115900685.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SPRC","BK4007","CMND"],"gpt_icon":0},{"id":"2521172612","title":"Psychedelic: Exclusive talk with biotech company Clearmind Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2521172612","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521172612?lang=en_us&edition=fundamental","pubTime":"2025-03-22 22:30","pubTimestamp":1742653811,"startTime":"0","endTime":"0","summary":"In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Mark Haden, vice president of business development at Clearmind Medicine , a psychedelic pharmaceutical biotech company focused on development of therapeutics to solve underserved health problems. Here are some highlights:. Discover stocks' market position with detailed  competitor analyses.“Think of this space as being two overlapping circles, a Venn diagram,” Haden said. “There are addiction treatments, like counseling, Alcoholics Anonymous and some pharmaceutical interventions like Antabuse, naltrexone and acamprosate. I ran an addictions treatment program for 28 years and I can assure you that there is relatively low efficacy, the dropout rate is high, and the treatments tend to be very long-term. That’s the first circle.”“You can take MEAI if you are addicted to alcohol and you don’t want to stop,” Haden said. “You can add MEAI to your alcohol and we believe it will result in people drinking less. It c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-exclusive-talk-biotech-company-143011967.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-exclusive-talk-biotech-company-143011967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4202","MYCOF","PBM","ENTBF","AGNPF","CYBN","BETRF","DRUG","RVVTF","BK4539","NUMIF","SPRC","BK4007","SEEL","RLMD","CMPS","PHRRF","CMND","SNPX","BK4547","MIRA","ALID","GHRS","PSYGF","MNMD","QNTM","ATAI","SILO","MDXXF","IXHL","BK4139","NRXP","OPTHF","KTTA","BK4168","FLHLF"],"gpt_icon":0},{"id":"2519638156","title":"Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2519638156","media":"TipRanks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519638156?lang=en_us&edition=fundamental","pubTime":"2025-03-14 23:40","pubTimestamp":1741966809,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a dosing initiation, a development expansion and a distribution agreement.Discover stocks' market position with detailed  competitor analyses.MIRA EXPANDS KETAMIR-2 DEVELOPMENT WITH TOPICAL: On Thursday, MIRA Pharmaceuticals  announced the formulation of Ketamir-2 into a topical treatment for localized neuropathic and inflammatory pain. This expands the company’s pain management portfolio beyond its ongoing Ketamir-2 oral treatment for neuropathic pain, offering a novel, targeted approach for localized pain relief. The topical treatment of Ketamir-2 is designed for slow release, delivering targeted pain relief directly at the application site while minimizing systemic exposure and side effects.“The development of both an oral and topical formulation of Ketamir-2 significantly expands our pipeline and enhances the value proposition of MIRA,” stated Erez Aminov, CEO . “By adv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-atai-reports-dosing-first-154009720.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-atai-reports-dosing-first-154009720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IXHL","MNMD","PSYGF","DRUG","SPRC","MDXXF","RVVTF","BK4202","BK4547","FLHLF","BK4139","AGNPF","SEEL","GHRS","OPTHF","ATAI","ENVB","NUMIF","BK4539","RLMD","QNTM","BK4168","ALID","BETRF","CMND","PBM","CMPS","NRXP","BK4007","SNPX","SILO","MIRA","ENTBF","KTTA","MYCOF","CYBN","PHRRF"],"gpt_icon":0},{"id":"2518486225","title":"BRIEF-Scisparc, Clearmind apply for patent in South Korea for its co-developed treatment to overcome cocaine addiction","url":"https://stock-news.laohu8.com/highlight/detail?id=2518486225","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518486225?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:32","pubTimestamp":1741609945,"startTime":"0","endTime":"0","summary":"BRIEF-Scisparc, Clearmind apply for patent in South Korea for its co-developed treatment to overcome cocaine addictionMarch 10  - Clearmind Medicine Inc CMND.O:SCISPARC-CLEARMIND COLLABORATION LEADS TO PUBLICATION OF PATENT APPLICATION FOR COCAINE ADDICTION PSYCHEDELIC COMBINATION TREATMENT IN SOUTH KOREASource text: nGNX98FWdxFurther company coverage: CMND.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nTUA8LZPT2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","SPRC","BK4007","BK4139"],"gpt_icon":0},{"id":"2518424063","title":"Scisparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea","url":"https://stock-news.laohu8.com/highlight/detail?id=2518424063","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518424063?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:45","pubTimestamp":1741607100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nTUA8LZPT2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","SPRC","BK4007","BK4139"],"gpt_icon":0},{"id":"2518223006","title":"SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea","url":"https://stock-news.laohu8.com/highlight/detail?id=2518223006","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518223006?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:45","pubTimestamp":1741607100,"startTime":"0","endTime":"0","summary":"The patent is based on preclinical trial results led by Professor Gal Yadid and his team at the Gonda Multidisciplinary Brain Research Center at Bar-Ilan University in Israel. These results followed an earlier experiment in which animals treated with MEAI exhibited a significant reduction in cocaine-induced craving.Building on these findings, further research assessed whether MEAI’s effect on drug-seeking behavior extends to natural rewards, as reward-based reinforcement is a fundamental survival mechanism across species. The study produced positive results, demonstrating that while MEAI reduced cocaine-seeking behavior, it did not impair the rats’ response to natural rewards, such as sucrose. This suggests that MEAI’s effect on drug craving is not linked to the general reward system but rather specifically targets drug-related compulsions.This latest publication adds to multiple patent applications already filed in the U.S. and other global territories as part of the ongoing SciSparc-","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scisparc-clearmind-collaboration-leads-publication-114500371.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CMND","BK4007","SPRC"],"gpt_icon":0},{"id":"2518247958","title":"Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea","url":"https://stock-news.laohu8.com/highlight/detail?id=2518247958","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518247958?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:27","pubTimestamp":1741606020,"startTime":"0","endTime":"0","summary":"Vancouver, Canada, March  10, 2025  (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the \"Company\"), a clinical-stage biotech company focused on discovery and d","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/10/3039620/0/en/Clearmind-Medicine-Announces-Publication-of-Patent-for-Cocaine-Addiction-Psychedelic-Combination-Treatment-in-South-Korea.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","SPRC"],"gpt_icon":0},{"id":"2516631221","title":"BRIEF-SciSparc Signs Definitive Agreement To Sell Mitocarex","url":"https://stock-news.laohu8.com/highlight/detail?id=2516631221","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516631221?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:30","pubTimestamp":1741012224,"startTime":"0","endTime":"0","summary":"BRIEF-SciSparc Signs Definitive Agreement To Sell MitocarexMarch 3 (Reuters) - Scisparc Ltd SPRC.O:SCISPARC SIGNS DEFINITIVE AGREEMENT TO SELL MITOCAREX, COMPUTATIONAL DRUG DISCOVERY COMPANY TARGETING","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA7PDTWK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","SPRC"],"gpt_icon":0},{"id":"2516636018","title":"SciSparc signs definitive agreement to sell MitoCareX to N2OFF","url":"https://stock-news.laohu8.com/highlight/detail?id=2516636018","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516636018?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:36","pubTimestamp":1741009008,"startTime":"0","endTime":"0","summary":"SciSparc (SPRC)has signed a definitive agreement to sell its entire ownership interest in MitoCareX Bio to N2Off (NITO). SciSparc currently owns 52...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scisparc-signs-definitive-agreement-to-sell-mitocarex-to-n2off?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scisparc-signs-definitive-agreement-to-sell-mitocarex-to-n2off?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SPRC","BK4093","BK4007","NITO"],"gpt_icon":0},{"id":"2516351956","title":"Scisparc Signs Definitive Agreement to Sell Mitocarex, Computational Drug Discovery Company Targeting Resistant Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2516351956","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516351956?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:25","pubTimestamp":1741008300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA7PDTWK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRC","BK4007","BK4139"],"gpt_icon":0},{"id":"2516635427","title":"SciSparc Signs Definitive Agreement to Sell MitoCareX, Computational Drug Discovery Company Targeting Resistant Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2516635427","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516635427?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:25","pubTimestamp":1741008300,"startTime":"0","endTime":"0","summary":"SciSparc will sell its MitoCareX’s shares for $700,000 and exchange its remaining shares for common stock in N2OFF. SciSparc Ltd. has entered into a Securities Purchase and Exchange Agreement with N2OFF, under which SciSparc and other sellers, including Dr. Alon Silberman and Prof. Ciro Leonardo Pierri, will transfer full ownership of MitoCareX Bio Ltd. to N2OFF. As part of the agreement, SciSparc will sell 4,961 shares of MitoCareX to N2OFF for $700,000 and exchange its remaining shares for common stock in N2OFF. In total, SciSparc and the other sellers will receive N2OFF common stock equivalent to 40% of the company’s fully diluted capital stock. The transaction is subject to certain conditions, including approval of N2OFF’s shareholders. Upon closing, MitoCareX will become a wholly owned subsidiary of N2OFF, with its board restructured under N2OFF’s control.SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientis","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scisparc-signs-definitive-agreement-sell-132500084.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SPRC","BK4139","BK4007"],"gpt_icon":0},{"id":"2514155353","title":"Scisparc Ltd: on Feb 25, Co Entered Securities Purchase Agreements to Sell, Issue to Debentures in Aggregate Principal Amount of $4.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514155353","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514155353?lang=en_us&edition=fundamental","pubTime":"2025-02-28 05:37","pubTimestamp":1740692251,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI2BD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","SPRC"],"gpt_icon":0},{"id":"2514807756","title":"SciSparc extends $2M loan to support AutoMax growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2514807756","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514807756?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:50","pubTimestamp":1740664250,"startTime":"0","endTime":"0","summary":"SciSparc (SPRC)has entered into a loan agreement with AutoMax Motors to provide a $2 million loan. The funding will support AutoMax’s business expa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scisparc-extends-2m-loan-to-support-automax-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scisparc-extends-2m-loan-to-support-automax-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SPRC","BK4139"],"gpt_icon":0},{"id":"2514994807","title":"Scisparc Extends $2 Million Loan to Support Automax's Growth Following Automax’s Entry Into Direct Import of Jac Electric Vehicles","url":"https://stock-news.laohu8.com/highlight/detail?id=2514994807","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514994807?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:45","pubTimestamp":1740663912,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI1BZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRC","BK4139","BK4007"],"gpt_icon":0},{"id":"2514074848","title":"SciSparc Extends $2 Million Loan to Support AutoMax's Growth Following AutoMax’s Entry into Direct Import of JAC Electric Vehicles","url":"https://stock-news.laohu8.com/highlight/detail?id=2514074848","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514074848?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:45","pubTimestamp":1740663900,"startTime":"0","endTime":"0","summary":"TEL AVIV, Israel, Feb. 27, 2025  -- SciSparc Ltd.  , a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced today that it has entered into a loan agreement with AutoMax Motors Ltd.  to provide a $2 million loan . The funding will support AutoMax's business expansion following its entry into the direct import of Anhui Jianghuai Automobile Group Corp., Ltd.  electric vehicles. The New Loan is in addition to previous bridge loans in an aggregate amount of $4.25 million . The Previous Loans were provided in lieu of SciSparc’s obligation to provide a $4.25 million closing financing, in accordance with the merger agreement signed between the parties.In April 2024, SciSparc and AutoMax signed a merger agreement under which SciSparc will acquire 100% of AutoMax, aiming to expand into the automotive sector. The merger is subject to customary closing conditions, including shareholder approvals from bo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scisparc-extends-2-million-loan-134500716.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SPRC","BK4007","BK4139"],"gpt_icon":0},{"id":"2514276851","title":"N2OFF to Acquire Biotech Firm MitoCareX Bio; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2514276851","media":"MT Newswires Live","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514276851?lang=en_us&edition=fundamental","pubTime":"2025-02-26 23:16","pubTimestamp":1740582985,"startTime":"0","endTime":"0","summary":"N2OFF  said Wednesday that it signed a definitive deal to acquire the biotech company MitoCareX Bio from owners Alon Silberman, Ciro Leonardo Pierri and SciSparc Under the terms, N2OFF will purchase 4,961 MitoCareX shares from SciSparc for $700,000 and exchange additional shares with the all sellers for stock totaling 40% of its outstanding share capital.N2OFF said the sellers will also be entitled to 30% of its financing proceeds, up to a maximum of $1.6 million, over five years and milestone-based issuances of up to 25% of its common shares.MitoCareX will become a subsidiary of N2OFF after closing of the transaction, which remains subject to approval by N2OFF shareholders, the company said.N2OFF shares were down more than 15% in recent trading Wednesday.Price: 0.52, Change: -0.05, Percent Change: -9.41","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","NITO","SPRC","BK4139","BK4093"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":58,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPRC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-24","symbol":"SPRC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1745467200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-09-28","symbol":"SPRC","defaultRemindTime":1695907800000,"type":"split","dateTimestamp":1695873600000,"forFactor":26,"toFactor":1,"ratio":26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPRC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPRC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SPRC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SPRC","date":"2025-06-06","current":-0.568058,"percent":0.608907,"low":-6.13257,"twenty":-3.208301,"median":-0.746653,"eighty":-0.281387,"high":18.797606,"avg":-0.693419,"sd":3.520344,"marketCap":3569676},"quantilePoints":[{"date":"2020-06-12","current":-0.583569,"twenty":-2.525956,"median":-1.68335,"eighty":-0.788462,"marketCap":4604363},{"date":"2020-06-19","current":-2.204005,"twenty":-2.495457,"median":-1.695745,"eighty":-0.802743,"marketCap":10566002},{"date":"2020-06-26","current":-2.107852,"twenty":-2.486751,"median":-1.699756,"eighty":-0.805238,"marketCap":10105043},{"date":"2020-07-02","current":-0.93156,"twenty":-2.481737,"median":-1.699756,"eighty":-0.818659,"marketCap":4465897},{"date":"2020-07-10","current":-0.528961,"twenty":-2.472055,"median":-1.695745,"eighty":-0.784455,"marketCap":2535840},{"date":"2020-07-17","current":-0.424638,"twenty":-2.465468,"median":-1.68335,"eighty":-0.753754,"marketCap":2035716},{"date":"2020-07-24","current":-0.499281,"twenty":-2.457358,"median":-1.671827,"eighty":-0.743548,"marketCap":2393551},{"date":"2020-07-31","current":-0.496636,"twenty":-2.446216,"median":-1.661099,"eighty":-0.720968,"marketCap":2380872},{"date":"2020-08-07","current":-0.426108,"twenty":-2.429241,"median":-1.648988,"eighty":-0.677605,"marketCap":2042760},{"date":"2020-08-14","current":-0.382028,"twenty":-2.425584,"median":-1.642136,"eighty":-0.565035,"marketCap":1831440},{"date":"2020-08-21","current":-0.484587,"twenty":-2.42523,"median":-1.630826,"eighty":-0.535024,"marketCap":2323111},{"date":"2020-08-28","current":-0.457552,"twenty":-2.416181,"median":-1.628337,"eighty":-0.512942,"marketCap":2193502},{"date":"2020-09-04","current":-0.379089,"twenty":-2.405651,"median":-1.616222,"eighty":-0.499281,"marketCap":1817352},{"date":"2020-09-11","current":-0.402892,"twenty":-2.403268,"median":-1.606486,"eighty":-0.491934,"marketCap":1931465},{"date":"2020-09-18","current":-0.422875,"twenty":-2.402868,"median":-1.60192,"eighty":-0.476975,"marketCap":2027263},{"date":"2020-09-25","current":-0.323254,"twenty":-2.399378,"median":-1.598742,"eighty":-0.469258,"marketCap":1549680},{"date":"2020-10-02","current":-0.271387,"twenty":-2.387255,"median":-1.585983,"eighty":-0.458081,"marketCap":1301027},{"date":"2020-10-09","current":-0.257972,"twenty":-2.3805,"median":-1.575903,"eighty":-0.442224,"marketCap":1239039},{"date":"2020-10-16","current":-0.35198,"twenty":-2.380358,"median":-1.571335,"eighty":-0.439273,"marketCap":1690560},{"date":"2020-10-23","current":-0.346951,"twenty":-2.380336,"median":-1.55761,"eighty":-0.430927,"marketCap":1666407},{"date":"2020-10-30","current":-0.291221,"twenty":-2.373615,"median":-1.540522,"eighty":-0.426108,"marketCap":1398736},{"date":"2020-11-06","current":-0.251503,"twenty":-2.355092,"median":-1.533463,"eighty":-0.423933,"marketCap":1207968},{"date":"2020-11-13","current":-0.188627,"twenty":-2.34297,"median":-1.51534,"eighty":-0.420377,"marketCap":905976},{"date":"2020-11-20","current":-0.75551,"twenty":-2.331912,"median":-1.496126,"eighty":-0.411414,"marketCap":3628716},{"date":"2020-11-27","current":-0.701545,"twenty":-2.32071,"median":-1.48491,"eighty":-0.412707,"marketCap":3369522},{"date":"2020-12-04","current":-0.947626,"twenty":-2.310196,"median":-1.449008,"eighty":-0.41688,"marketCap":4551446},{"date":"2020-12-11","current":-0.960577,"twenty":-2.304251,"median":-1.439765,"eighty":-0.420328,"marketCap":4613653},{"date":"2020-12-18","current":-0.852647,"twenty":-2.301925,"median":-1.432079,"eighty":-0.420495,"marketCap":4095265},{"date":"2020-12-24","current":-0.75551,"twenty":-2.298564,"median":-1.421136,"eighty":-0.420694,"marketCap":3628716},{"date":"2020-12-31","current":-0.809475,"twenty":-2.285122,"median":-1.41176,"eighty":-0.421376,"marketCap":3887910},{"date":"2021-01-08","current":-0.809475,"twenty":-2.280848,"median":-1.41176,"eighty":-0.422875,"marketCap":3887910},{"date":"2021-01-15","current":-0.679959,"twenty":-2.270866,"median":-1.400527,"eighty":-0.424638,"marketCap":3265844},{"date":"2021-01-22","current":-0.885026,"twenty":-2.270866,"median":-1.387419,"eighty":-0.424768,"marketCap":4250781},{"date":"2021-01-29","current":-0.97137,"twenty":-2.253295,"median":-1.362909,"eighty":-0.425846,"marketCap":4665492},{"date":"2021-02-05","current":-1.241196,"twenty":-2.246514,"median":-1.34301,"eighty":-0.426108,"marketCap":5961462},{"date":"2021-02-12","current":-1.362077,"twenty":-2.245912,"median":-1.338738,"eighty":-0.426108,"marketCap":6542056},{"date":"2021-02-19","current":-1.983754,"twenty":-2.242265,"median":-1.343606,"eighty":-0.426108,"marketCap":9527971},{"date":"2021-02-26","current":-1.616792,"twenty":-2.235969,"median":-1.362493,"eighty":-0.426637,"marketCap":7765452},{"date":"2021-03-05","current":-1.478641,"twenty":-2.230571,"median":-1.387419,"eighty":-0.428664,"marketCap":7101915},{"date":"2021-03-12","current":-1.564986,"twenty":-2.218863,"median":-1.400527,"eighty":-0.430927,"marketCap":7516626},{"date":"2021-03-19","current":-1.888776,"twenty":-2.21151,"median":-1.41176,"eighty":-0.431867,"marketCap":9071790},{"date":"2021-03-26","current":-1.813225,"twenty":-2.20798,"median":-1.41176,"eighty":-0.432866,"marketCap":8708918},{"date":"2021-04-01","current":-4.735013,"twenty":-2.222139,"median":-1.421136,"eighty":-0.434865,"marketCap":16487315},{"date":"2021-04-09","current":-5.307891,"twenty":-2.245915,"median":-1.434641,"eighty":-0.438509,"marketCap":18482076},{"date":"2021-04-16","current":-5.407268,"twenty":-2.276855,"median":-1.437617,"eighty":-0.440801,"marketCap":18828106},{"date":"2021-04-23","current":-5.24783,"twenty":-2.304251,"median":-1.448003,"eighty":-0.440801,"marketCap":18272944},{"date":"2021-04-30","current":-6.06443,"twenty":-2.34389,"median":-1.476108,"eighty":-0.440919,"marketCap":21116344},{"date":"2021-05-07","current":-4.619869,"twenty":-2.380368,"median":-1.491711,"eighty":-0.441847,"marketCap":16086383},{"date":"2021-05-14","current":-5.383033,"twenty":-2.402932,"median":-1.502553,"eighty":-0.444057,"marketCap":18743721},{"date":"2021-05-21","current":-5.512499,"twenty":-2.425407,"median":-1.511021,"eighty":-0.449605,"marketCap":19194520},{"date":"2021-05-28","current":-5.444359,"twenty":-2.460853,"median":-1.518138,"eighty":-0.456317,"marketCap":18957257},{"date":"2021-06-04","current":-5.573824,"twenty":-2.485498,"median":-1.526949,"eighty":-0.457728,"marketCap":19408056},{"date":"2021-06-11","current":-4.953753,"twenty":-2.53283,"median":-1.537116,"eighty":-0.458551,"marketCap":17248969},{"date":"2021-06-18","current":-5.110474,"twenty":-2.614185,"median":-1.546212,"eighty":-0.460489,"marketCap":17794672},{"date":"2021-06-25","current":-5.444359,"twenty":-2.685111,"median":-1.562827,"eighty":-0.466751,"marketCap":18957257},{"date":"2021-07-02","current":-5.314893,"twenty":-2.788923,"median":-1.566263,"eighty":-0.468623,"marketCap":18506459},{"date":"2021-07-09","current":-5.110474,"twenty":-2.849812,"median":-1.571335,"eighty":-0.469894,"marketCap":17794672},{"date":"2021-07-16","current":-4.940125,"twenty":-2.89473,"median":-1.575903,"eighty":-0.470188,"marketCap":17201516},{"date":"2021-07-23","current":-4.531287,"twenty":-3.054439,"median":-1.584726,"eighty":-0.470188,"marketCap":15777942},{"date":"2021-07-30","current":-3.563704,"twenty":-3.478667,"median":-1.596749,"eighty":-0.470188,"marketCap":12408818},{"date":"2021-08-06","current":-3.611402,"twenty":-3.603064,"median":-1.600529,"eighty":-0.481499,"marketCap":12574901},{"date":"2021-08-13","current":-3.372913,"twenty":-3.577332,"median":-1.606486,"eighty":-0.484587,"marketCap":11744483},{"date":"2021-08-20","current":-3.442104,"twenty":-3.563704,"median":-1.612224,"eighty":-0.484881,"marketCap":12026712},{"date":"2021-08-27","current":-2.604682,"twenty":-3.495564,"median":-1.616792,"eighty":-0.484881,"marketCap":9100760},{"date":"2021-09-03","current":-3.907023,"twenty":-3.603064,"median":-1.627851,"eighty":-0.496636,"marketCap":13651140},{"date":"2021-09-10","current":-3.418645,"twenty":-3.604732,"median":-1.63023,"eighty":-0.497811,"marketCap":11944747},{"date":"2021-09-17","current":-3.809348,"twenty":-3.611402,"median":-1.630826,"eighty":-0.499046,"marketCap":13309861},{"date":"2021-09-24","current":-3.907023,"twenty":-3.713611,"median":-1.642136,"eighty":-0.499281,"marketCap":13651140},{"date":"2021-10-01","current":-3.776789,"twenty":-3.713611,"median":-1.648988,"eighty":-0.500018,"marketCap":13196102},{"date":"2021-10-08","current":-3.907023,"twenty":-3.721824,"median":-1.654938,"eighty":-0.505422,"marketCap":13651140},{"date":"2021-10-15","current":-3.685625,"twenty":-3.731207,"median":-1.667259,"eighty":-0.506882,"marketCap":12877575},{"date":"2021-10-22","current":-3.679114,"twenty":-3.776789,"median":-1.675262,"eighty":-0.512942,"marketCap":12854823},{"date":"2021-10-29","current":-4.082839,"twenty":-3.81586,"median":-1.686677,"eighty":-0.526058,"marketCap":14265441},{"date":"2021-11-05","current":-4.96192,"twenty":-3.872945,"median":-1.697277,"eighty":-0.529903,"marketCap":17336947},{"date":"2021-11-12","current":-4.753545,"twenty":-3.901814,"median":-1.700279,"eighty":-0.534042,"marketCap":16608887},{"date":"2021-11-19","current":-4.590752,"twenty":-3.907023,"median":-1.706592,"eighty":-0.535024,"marketCap":16040089},{"date":"2021-11-26","current":-4.558194,"twenty":-3.907023,"median":-1.711143,"eighty":-0.543256,"marketCap":15926330},{"date":"2021-12-03","current":-4.51717,"twenty":-3.907023,"median":-1.712938,"eighty":-0.552448,"marketCap":15782993},{"date":"2021-12-10","current":-4.818662,"twenty":-3.976784,"median":-1.726881,"eighty":-0.559403,"marketCap":16836406},{"date":"2021-12-17","current":-4.942385,"twenty":-4.046506,"median":-1.735777,"eighty":-0.564375,"marketCap":17268692},{"date":"2021-12-23","current":-4.486565,"twenty":-4.080572,"median":-1.741085,"eighty":-0.572845,"marketCap":15676059},{"date":"2021-12-31","current":-4.056793,"twenty":-4.092235,"median":-1.745619,"eighty":-0.591589,"marketCap":14174433},{"date":"2022-01-07","current":-5.548142,"twenty":-4.117304,"median":-1.754048,"eighty":-0.619892,"marketCap":19385209},{"date":"2022-01-14","current":-5.431339,"twenty":-4.167492,"median":-1.7609,"eighty":-0.658566,"marketCap":18977100},{"date":"2022-01-21","current":-4.94643,"twenty":-4.199063,"median":-1.767427,"eighty":-0.679959,"marketCap":17282826},{"date":"2022-01-28","current":-4.459751,"twenty":-4.228949,"median":-1.76829,"eighty":-0.681153,"marketCap":15582369},{"date":"2022-02-04","current":-4.592481,"twenty":-4.300345,"median":-1.772569,"eighty":-0.687326,"marketCap":16046130},{"date":"2022-02-11","current":-4.5908,"twenty":-4.362843,"median":-1.775195,"eighty":-0.694258,"marketCap":16040256},{"date":"2022-02-18","current":-4.291625,"twenty":-4.376658,"median":-1.785795,"eighty":-0.700027,"marketCap":14994939},{"date":"2022-02-25","current":-4.344718,"twenty":-4.362843,"median":-1.79096,"eighty":-0.701545,"marketCap":15180443},{"date":"2022-03-04","current":-3.539485,"twenty":-4.362843,"median":-1.795159,"eighty":-0.703704,"marketCap":12366960},{"date":"2022-03-11","current":-3.141293,"twenty":-4.362843,"median":-1.798379,"eighty":-0.713367,"marketCap":10975677},{"date":"2022-03-18","current":-3.698762,"twenty":-4.355817,"median":-1.802092,"eighty":-0.718814,"marketCap":12923473},{"date":"2022-03-25","current":-4.088105,"twenty":-4.344718,"median":-1.807471,"eighty":-0.719403,"marketCap":14283838},{"date":"2022-04-01","current":-3.247477,"twenty":-4.344718,"median":-1.81285,"eighty":-0.721359,"marketCap":11346685},{"date":"2022-04-08","current":-3.251902,"twenty":-4.335869,"median":-1.813225,"eighty":-0.727085,"marketCap":11362144},{"date":"2022-04-14","current":-2.831588,"twenty":-4.320887,"median":-1.820464,"eighty":-0.729103,"marketCap":9893568},{"date":"2022-04-22","current":-2.389152,"twenty":-4.312027,"median":-1.823609,"eighty":-0.733061,"marketCap":8347698},{"date":"2022-04-29","current":-1.554795,"twenty":-4.29545,"median":-1.823609,"eighty":-0.739428,"marketCap":9000706},{"date":"2022-05-06","current":-1.527227,"twenty":-4.265308,"median":-1.822699,"eighty":-0.740804,"marketCap":8841119},{"date":"2022-05-13","current":-1.692631,"twenty":-4.255203,"median":-1.813225,"eighty":-0.743548,"marketCap":9798641},{"date":"2022-05-20","current":-1.32323,"twenty":-4.24877,"median":-1.81285,"eighty":-0.74462,"marketCap":7660176},{"date":"2022-05-27","current":-1.582362,"twenty":-4.235564,"median":-1.809586,"eighty":-0.746444,"marketCap":9160293},{"date":"2022-06-03","current":-1.725712,"twenty":-4.230413,"median":-1.804952,"eighty":-0.747307,"marketCap":9990146},{"date":"2022-06-10","current":-1.587875,"twenty":-4.228949,"median":-1.802092,"eighty":-0.747636,"marketCap":9192211},{"date":"2022-06-17","current":-1.042043,"twenty":-4.227199,"median":-1.798379,"eighty":-0.749639,"marketCap":6032388},{"date":"2022-06-24","current":-1.232257,"twenty":-4.218556,"median":-1.795936,"eighty":-0.752355,"marketCap":7133538},{"date":"2022-07-01","current":-1.317716,"twenty":-4.204425,"median":-1.791387,"eighty":-0.754482,"marketCap":7628258},{"date":"2022-07-08","current":-1.199177,"twenty":-4.199063,"median":-1.79096,"eighty":-0.75472,"marketCap":6942034},{"date":"2022-07-15","current":-0.926261,"twenty":-4.193569,"median":-1.782869,"eighty":-0.75551,"marketCap":5362123},{"date":"2022-07-22","current":-0.931774,"twenty":-4.1834,"median":-1.775195,"eighty":-0.75551,"marketCap":5394040},{"date":"2022-07-29","current":-0.871126,"twenty":-4.167492,"median":-1.771065,"eighty":-0.75551,"marketCap":5042949},{"date":"2022-08-05","current":-0.716749,"twenty":-4.162485,"median":-1.76829,"eighty":-0.75551,"marketCap":4149262},{"date":"2022-08-12","current":-0.617507,"twenty":-4.142459,"median":-1.765435,"eighty":-0.751656,"marketCap":3574748},{"date":"2022-08-19","current":-0.981164,"twenty":-4.14164,"median":-1.758793,"eighty":-0.74702,"marketCap":5679959},{"date":"2022-08-26","current":-1.128156,"twenty":-4.136183,"median":-1.756332,"eighty":-0.747609,"marketCap":6530896},{"date":"2022-09-02","current":-0.838928,"twenty":-4.122379,"median":-1.745619,"eighty":-0.748322,"marketCap":4856554},{"date":"2022-09-09","current":-0.812936,"twenty":-4.10208,"median":-1.745619,"eighty":-0.750956,"marketCap":4706087},{"date":"2022-09-16","current":-1.039452,"twenty":-4.093622,"median":-1.738061,"eighty":-0.754454,"marketCap":6017389},{"date":"2022-09-23","current":-0.840587,"twenty":-4.090155,"median":-1.726881,"eighty":-0.754523,"marketCap":4866158},{"date":"2022-09-30","current":-0.928296,"twenty":-4.088105,"median":-1.723892,"eighty":-0.75551,"marketCap":5373903},{"date":"2022-10-07","current":-1.072854,"twenty":-4.082839,"median":-1.712938,"eighty":-0.75551,"marketCap":6210754},{"date":"2022-10-14","current":-1.106036,"twenty":-4.082568,"median":-1.708858,"eighty":-0.75551,"marketCap":6402840},{"date":"2022-10-21","current":-0.952407,"twenty":-4.077577,"median":-1.703802,"eighty":-0.75551,"marketCap":5513485},{"date":"2022-10-28","current":-1.050734,"twenty":-4.070408,"median":-1.699022,"eighty":-0.75551,"marketCap":6082698},{"date":"2022-11-04","current":-1.128156,"twenty":-4.069816,"median":-1.694666,"eighty":-0.75551,"marketCap":6530896},{"date":"2022-11-11","current":-1.172398,"twenty":-4.069816,"median":-1.689654,"eighty":-0.75551,"marketCap":6787010},{"date":"2022-11-18","current":-1.128156,"twenty":-4.059791,"median":-1.680024,"eighty":-0.75551,"marketCap":6530896},{"date":"2022-11-25","current":-1.128156,"twenty":-4.057393,"median":-1.672916,"eighty":-0.75551,"marketCap":6530896},{"date":"2022-12-02","current":-1.26088,"twenty":-4.041478,"median":-1.667259,"eighty":-0.7635,"marketCap":7299237},{"date":"2022-12-09","current":-1.056264,"twenty":-4.037336,"median":-1.654938,"eighty":-0.766195,"marketCap":6114712},{"date":"2022-12-16","current":-0.906949,"twenty":-4.034985,"median":-1.64908,"eighty":-0.768016,"marketCap":5250328},{"date":"2022-12-23","current":-0.840587,"twenty":-4.03148,"median":-1.64442,"eighty":-0.773463,"marketCap":4866158},{"date":"2022-12-30","current":-0.572088,"twenty":-4.024442,"median":-1.638252,"eighty":-0.767604,"marketCap":5090438},{"date":"2023-01-06","current":-0.617446,"twenty":-3.913357,"median":-1.629743,"eighty":-0.75551,"marketCap":5494034},{"date":"2023-01-13","current":-0.757231,"twenty":-3.907023,"median":-1.616222,"eighty":-0.75551,"marketCap":6737840},{"date":"2023-01-20","current":-0.639254,"twenty":-3.907023,"median":-1.606486,"eighty":-0.75551,"marketCap":5688084},{"date":"2023-01-27","current":-0.677721,"twenty":-3.900512,"median":-1.598902,"eighty":-0.748451,"marketCap":6030360},{"date":"2023-02-03","current":-0.704225,"twenty":-3.856689,"median":-1.585038,"eighty":-0.742862,"marketCap":6266191},{"date":"2023-02-10","current":-0.632288,"twenty":-3.789813,"median":-1.575903,"eighty":-0.724795,"marketCap":5626096},{"date":"2023-02-17","current":-0.77097,"twenty":-3.740841,"median":-1.564986,"eighty":-0.717988,"marketCap":6860090},{"date":"2023-02-24","current":-0.709369,"twenty":-3.726416,"median":-1.554795,"eighty":-0.715396,"marketCap":6311968},{"date":"2023-03-03","current":-0.601356,"twenty":-3.7039,"median":-1.537116,"eighty":-0.704017,"marketCap":5350870},{"date":"2023-03-10","current":-0.539679,"twenty":-3.638741,"median":-1.527227,"eighty":-0.693488,"marketCap":4802063},{"date":"2023-03-17","current":-0.416362,"twenty":-3.606399,"median":-1.514059,"eighty":-0.686048,"marketCap":3704791},{"date":"2023-03-24","current":-0.400904,"twenty":-3.549173,"median":-1.496126,"eighty":-0.68159,"marketCap":3567246},{"date":"2023-03-31","current":-0.346936,"twenty":-3.517414,"median":-1.476108,"eighty":-0.677722,"marketCap":3087040},{"date":"2023-04-06","current":-0.344315,"twenty":-3.506536,"median":-1.446446,"eighty":-0.654806,"marketCap":3063716},{"date":"2023-04-14","current":-0.400904,"twenty":-3.444409,"median":-1.429517,"eighty":-0.632288,"marketCap":3567246},{"date":"2023-04-21","current":-0.439453,"twenty":-3.399905,"median":-1.41176,"eighty":-0.617483,"marketCap":3910251},{"date":"2023-04-28","current":-0.53382,"twenty":-3.372095,"median":-1.397156,"eighty":-0.598426,"marketCap":4749926},{"date":"2023-05-05","current":-0.480314,"twenty":-3.372095,"median":-1.370023,"eighty":-0.570812,"marketCap":4273836},{"date":"2023-05-12","current":-0.484169,"twenty":-3.372095,"median":-1.343606,"eighty":-0.556114,"marketCap":4308136},{"date":"2023-05-19","current":-1.61445,"twenty":-3.372095,"median":-1.343606,"eighty":-0.556114,"marketCap":4184654},{"date":"2023-05-26","current":-1.724034,"twenty":-3.372095,"median":-1.343606,"eighty":-0.556114,"marketCap":4468697},{"date":"2023-06-02","current":-2.312084,"twenty":-3.372095,"median":-1.343606,"eighty":-0.556114,"marketCap":5992921},{"date":"2023-06-09","current":-1.632094,"twenty":-3.372095,"median":-1.343606,"eighty":-0.556114,"marketCap":4230388},{"date":"2023-06-16","current":-1.587593,"twenty":-3.372095,"median":-1.343606,"eighty":-0.556114,"marketCap":4115042},{"date":"2023-06-23","current":-1.532103,"twenty":-3.372368,"median":-1.34301,"eighty":-0.555776,"marketCap":3971212},{"date":"2023-06-30","current":-1.643251,"twenty":-3.37264,"median":-1.342414,"eighty":-0.555437,"marketCap":4259306},{"date":"2023-07-07","current":-1.479176,"twenty":-3.37264,"median":-1.342414,"eighty":-0.555437,"marketCap":3834025},{"date":"2023-07-14","current":-1.55996,"twenty":-3.37264,"median":-1.342414,"eighty":-0.555437,"marketCap":4043416},{"date":"2023-07-21","current":-1.509044,"twenty":-3.37264,"median":-1.342414,"eighty":-0.555437,"marketCap":3911443},{"date":"2023-07-28","current":-1.446354,"twenty":-3.37264,"median":-1.342414,"eighty":-0.555437,"marketCap":3748949},{"date":"2023-08-04","current":-1.205678,"twenty":-3.37264,"median":-1.334015,"eighty":-0.555437,"marketCap":3125118},{"date":"2023-08-11","current":-0.523416,"twenty":-3.37264,"median":-1.329002,"eighty":-0.555098,"marketCap":1356694},{"date":"2023-08-18","current":-0.855908,"twenty":-3.37264,"median":-1.314397,"eighty":-0.555098,"marketCap":2218513},{"date":"2023-08-25","current":-0.78425,"twenty":-3.37264,"median":-1.306548,"eighty":-0.555098,"marketCap":2032777},{"date":"2023-08-31","current":-0.749417,"twenty":-3.37264,"median":-1.300132,"eighty":-0.555098,"marketCap":1942489},{"date":"2023-09-08","current":-0.741455,"twenty":-3.372913,"median":-1.295412,"eighty":-0.555098,"marketCap":1921852},{"date":"2023-09-15","current":-0.78425,"twenty":-3.375548,"median":-1.28093,"eighty":-0.555062,"marketCap":2032777},{"date":"2023-09-20","current":-0.732,"twenty":-3.378183,"median":-1.274902,"eighty":-0.555026,"marketCap":1897345},{"date":"2023-09-29","current":-0.721549,"twenty":-3.387185,"median":-1.262264,"eighty":-0.554395,"marketCap":1870255},{"date":"2023-10-06","current":-0.893802,"twenty":-3.387185,"median":-1.254039,"eighty":-0.554395,"marketCap":2316735},{"date":"2023-10-13","current":-0.633508,"twenty":-3.387733,"median":-1.240568,"eighty":-0.554133,"marketCap":1642054},{"date":"2023-10-20","current":9.033801,"twenty":-3.388282,"median":-1.234816,"eighty":-0.549369,"marketCap":2592701},{"date":"2023-10-27","current":6.971537,"twenty":-3.388967,"median":-1.232257,"eighty":-0.547977,"marketCap":2000831},{"date":"2023-10-31","current":6.223282,"twenty":-3.388967,"median":-1.229692,"eighty":-0.542067,"marketCap":1786082},{"date":"2023-11-10","current":8.7783,"twenty":-3.34334,"median":-1.21981,"eighty":-0.53345,"marketCap":2519372},{"date":"2023-11-17","current":11.388063,"twenty":-3.233319,"median":-1.217034,"eighty":-0.520779,"marketCap":3268374},{"date":"2023-11-24","current":18.359603,"twenty":-3.211744,"median":-1.213243,"eighty":-0.506882,"marketCap":5269206},{"date":"2023-12-01","current":14.253331,"twenty":-3.208301,"median":-1.204597,"eighty":-0.497924,"marketCap":4090706},{"date":"2023-12-08","current":11.753066,"twenty":-3.208301,"median":-1.194518,"eighty":-0.489257,"marketCap":3373130},{"date":"2023-12-15","current":11.406314,"twenty":-3.208301,"median":-1.185393,"eighty":-0.484169,"marketCap":3273612},{"date":"2023-12-22","current":8.814798,"twenty":-3.208301,"median":-1.174366,"eighty":-0.470188,"marketCap":2529847},{"date":"2023-12-29","current":8.942551,"twenty":-3.208301,"median":-1.172398,"eighty":-0.469576,"marketCap":2566512},{"date":"2024-01-05","current":9.316676,"twenty":-3.208301,"median":-1.168208,"eighty":-0.461158,"marketCap":2673886},{"date":"2024-01-12","current":7.820167,"twenty":-3.208301,"median":-1.154004,"eighty":-0.455121,"marketCap":2244388},{"date":"2024-01-19","current":6.661286,"twenty":-3.208301,"median":-1.146959,"eighty":-0.443517,"marketCap":1911789},{"date":"2024-01-26","current":15.131443,"twenty":-3.208301,"median":-1.141622,"eighty":-0.439992,"marketCap":4342724},{"date":"2024-02-02","current":8.935697,"twenty":-3.208301,"median":-1.132321,"eighty":-0.431809,"marketCap":2564545},{"date":"2024-02-09","current":9.133171,"twenty":-3.208301,"median":-1.128156,"eighty":-0.426108,"marketCap":2621220},{"date":"2024-02-16","current":8.738223,"twenty":-3.208301,"median":-1.128156,"eighty":-0.424275,"marketCap":2507870},{"date":"2024-02-23","current":9.528118,"twenty":-3.208301,"median":-1.122542,"eighty":-0.420495,"marketCap":2734570},{"date":"2024-03-01","current":9.429383,"twenty":-3.208301,"median":-1.117096,"eighty":-0.413065,"marketCap":2706233},{"date":"2024-03-08","current":8.886328,"twenty":-3.208301,"median":-1.106036,"eighty":-0.407063,"marketCap":2550376},{"date":"2024-03-15","current":6.39322,"twenty":-3.208301,"median":-1.088956,"eighty":-0.400904,"marketCap":1834854},{"date":"2024-03-22","current":5.134324,"twenty":-3.208301,"median":-1.074501,"eighty":-0.393287,"marketCap":1473551},{"date":"2024-03-28","current":4.295059,"twenty":-3.208301,"median":-1.064097,"eighty":-0.382204,"marketCap":1232682},{"date":"2024-04-05","current":-0.261411,"twenty":-3.208301,"median":-1.058149,"eighty":-0.375674,"marketCap":1338947},{"date":"2024-04-12","current":-0.246888,"twenty":-3.208301,"median":-1.050409,"eighty":-0.369881,"marketCap":1264561},{"date":"2024-04-19","current":-0.680933,"twenty":-3.208301,"median":-1.040282,"eighty":-0.369881,"marketCap":3487739},{"date":"2024-04-26","current":-0.665097,"twenty":-3.208301,"median":-1.028613,"eighty":-0.369942,"marketCap":3406629},{"date":"2024-05-03","current":-0.665097,"twenty":-3.208301,"median":-1.009257,"eighty":-0.369942,"marketCap":3406629},{"date":"2024-05-10","current":-0.675654,"twenty":-3.208301,"median":-0.98418,"eighty":-0.369942,"marketCap":3460702},{"date":"2024-05-17","current":-0.633426,"twenty":-3.208301,"median":-0.97137,"eighty":-0.369942,"marketCap":3244408},{"date":"2024-05-24","current":-0.612312,"twenty":-3.208301,"median":-0.959174,"eighty":-0.369942,"marketCap":3136261},{"date":"2024-05-31","current":-0.562469,"twenty":-3.208301,"median":-0.950527,"eighty":-0.369942,"marketCap":2880967},{"date":"2024-06-07","current":-0.54372,"twenty":-3.208301,"median":-0.94013,"eighty":-0.369942,"marketCap":2784935},{"date":"2024-06-14","current":-0.562469,"twenty":-3.208301,"median":-0.931774,"eighty":-0.369942,"marketCap":2880967},{"date":"2024-06-21","current":-0.587989,"twenty":-3.208301,"median":-0.92907,"eighty":-0.369881,"marketCap":3011679},{"date":"2024-06-28","current":-0.508037,"twenty":-3.208301,"median":-0.924789,"eighty":-0.369881,"marketCap":2602164},{"date":"2024-07-05","current":-0.477554,"twenty":-3.208301,"median":-0.918301,"eighty":-0.369881,"marketCap":2446034},{"date":"2024-07-12","current":-0.450882,"twenty":-3.208301,"median":-0.913767,"eighty":-0.369881,"marketCap":2309420},{"date":"2024-07-19","current":-0.408334,"twenty":-3.208301,"median":-0.905812,"eighty":-0.369881,"marketCap":2091489},{"date":"2024-07-26","current":-0.300123,"twenty":-3.208301,"median":-0.894562,"eighty":-0.364784,"marketCap":1537228},{"date":"2024-08-02","current":-0.234967,"twenty":-3.208301,"median":-0.890125,"eighty":-0.357342,"marketCap":1203500},{"date":"2024-08-09","current":-0.196864,"twenty":-3.208301,"median":-0.88349,"eighty":-0.351495,"marketCap":1008338},{"date":"2024-08-16","current":-0.234967,"twenty":-3.208301,"median":-0.875137,"eighty":-0.346942,"marketCap":1203500},{"date":"2024-08-23","current":-0.233062,"twenty":-3.208301,"median":-0.859982,"eighty":-0.342992,"marketCap":1193742},{"date":"2024-08-30","current":-0.22868,"twenty":-3.208301,"median":-0.852647,"eighty":-0.342685,"marketCap":1171299},{"date":"2024-09-06","current":-0.201945,"twenty":-3.208301,"median":-0.841693,"eighty":-0.339952,"marketCap":1034360},{"date":"2024-09-13","current":-0.190514,"twenty":-3.208301,"median":-0.837421,"eighty":-0.337042,"marketCap":975811},{"date":"2024-09-20","current":-0.167271,"twenty":-3.208301,"median":-0.826009,"eighty":-0.332813,"marketCap":856762},{"date":"2024-09-27","current":-0.158761,"twenty":-3.208301,"median":-0.817209,"eighty":-0.325793,"marketCap":813176},{"date":"2024-10-04","current":-0.142504,"twenty":-3.208301,"median":-0.810928,"eighty":-0.322648,"marketCap":729907},{"date":"2024-10-11","current":-0.142504,"twenty":-3.208301,"median":-0.806322,"eighty":-0.315586,"marketCap":729907},{"date":"2024-10-18","current":-0.145552,"twenty":-3.208301,"median":-0.798682,"eighty":-0.310219,"marketCap":745519},{"date":"2024-10-25","current":-0.14479,"twenty":-3.208301,"median":-0.788443,"eighty":-0.302518,"marketCap":741616},{"date":"2024-11-01","current":-0.148029,"twenty":-3.208301,"median":-0.783083,"eighty":-0.295018,"marketCap":758205},{"date":"2024-11-08","current":-0.150157,"twenty":-3.208301,"median":-0.775754,"eighty":-0.291046,"marketCap":853492},{"date":"2024-11-15","current":-0.143028,"twenty":-3.208301,"median":-0.768922,"eighty":-0.282905,"marketCap":812969},{"date":"2024-11-22","current":-0.154763,"twenty":-3.208301,"median":-0.763554,"eighty":-0.279708,"marketCap":879671},{"date":"2024-11-29","current":-0.135173,"twenty":-3.208301,"median":-0.75551,"eighty":-0.271481,"marketCap":768322},{"date":"2024-12-06","current":-0.150788,"twenty":-3.208301,"median":-0.75551,"eighty":-0.268179,"marketCap":857078},{"date":"2024-12-13","current":-0.171103,"twenty":-3.208301,"median":-0.752705,"eighty":-0.263445,"marketCap":972551},{"date":"2024-12-20","current":-0.134573,"twenty":-3.208301,"median":-0.747629,"eighty":-0.259144,"marketCap":764915},{"date":"2024-12-27","current":-0.270661,"twenty":-3.208301,"median":-0.747235,"eighty":-0.257546,"marketCap":1538438},{"date":"2025-01-03","current":-0.333058,"twenty":-3.208301,"median":-0.745574,"eighty":-0.254791,"marketCap":1893104},{"date":"2025-01-10","current":-0.51413,"twenty":-3.208301,"median":-0.744717,"eighty":-0.254643,"marketCap":2922316},{"date":"2025-01-17","current":-0.377916,"twenty":-3.208301,"median":-0.744717,"eighty":-0.254643,"marketCap":2148076},{"date":"2025-01-24","current":-0.364162,"twenty":-3.208301,"median":-0.744717,"eighty":-0.254643,"marketCap":2069899},{"date":"2025-01-31","current":-0.28391,"twenty":-3.208301,"median":-0.744717,"eighty":-0.254643,"marketCap":1613746},{"date":"2025-02-07","current":-0.312995,"twenty":-3.208301,"median":-0.744717,"eighty":-0.254204,"marketCap":1779066},{"date":"2025-02-14","current":-0.314636,"twenty":-3.208301,"median":-0.744717,"eighty":-0.254204,"marketCap":1788390},{"date":"2025-02-21","current":-0.281387,"twenty":-3.208301,"median":-0.744717,"eighty":-0.254204,"marketCap":1599402},{"date":"2025-02-28","current":-0.71058,"twenty":-3.208301,"median":-0.744717,"eighty":-0.252857,"marketCap":4038937},{"date":"2025-03-07","current":-0.608851,"twenty":-3.208301,"median":-0.745574,"eighty":-0.252726,"marketCap":3460709},{"date":"2025-03-14","current":-0.71439,"twenty":-3.208301,"median":-0.746653,"eighty":-0.253383,"marketCap":4060594},{"date":"2025-03-21","current":-0.621043,"twenty":-3.208301,"median":-0.746653,"eighty":-0.257262,"marketCap":3530009},{"date":"2025-03-28","current":-0.586752,"twenty":-3.208301,"median":-0.746653,"eighty":-0.257262,"marketCap":3335101},{"date":"2025-04-04","current":-0.515313,"twenty":-3.208301,"median":-0.746653,"eighty":-0.259967,"marketCap":2929041},{"date":"2025-04-11","current":-0.54041,"twenty":-3.208301,"median":-0.74643,"eighty":-0.262954,"marketCap":3071693},{"date":"2025-04-17","current":-0.538364,"twenty":-3.208301,"median":-0.74643,"eighty":-0.266642,"marketCap":3060063},{"date":"2025-04-25","current":-0.49282,"twenty":-3.208301,"median":-0.746653,"eighty":-0.270661,"marketCap":3096879},{"date":"2025-05-02","current":-0.497989,"twenty":-3.208301,"median":-0.746653,"eighty":-0.271623,"marketCap":3129364},{"date":"2025-05-09","current":-0.593279,"twenty":-3.208301,"median":-0.746653,"eighty":-0.278548,"marketCap":3728166},{"date":"2025-05-16","current":-0.544342,"twenty":-3.208301,"median":-0.746653,"eighty":-0.28069,"marketCap":3420644},{"date":"2025-05-23","current":-0.553785,"twenty":-3.208301,"median":-0.746653,"eighty":-0.281387,"marketCap":3479982},{"date":"2025-05-30","current":-0.544763,"twenty":-3.208301,"median":-0.746653,"eighty":-0.281387,"marketCap":3423292},{"date":"2025-06-06","current":-0.568058,"twenty":-3.208301,"median":-0.746653,"eighty":-0.281387,"marketCap":3569676}],"updateTime":1749472261941}}}